Milestone Scientific (MLSS)
(Delayed Data from AMEX)
$0.56 USD
-0.01 (-1.75%)
Updated Apr 26, 2024 03:58 PM ET
After-Market: $0.57 +0.01 (1.79%) 6:54 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.56 USD
-0.01 (-1.75%)
Updated Apr 26, 2024 03:58 PM ET
After-Market: $0.57 +0.01 (1.79%) 6:54 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Milestone Scientific, Inc. (MLSS) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Milestone Scientific, Inc. (MLSS) delivered earnings and revenue surprises of -50.00% and -6.31%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Milestone Scientific, Inc. (MLSS) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
by Zacks Equity Research
Milestone Scientific, Inc. (MLSS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Milestone Scientific, Inc. (MLSS) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Milestone Scientific, Inc. (MLSS) delivered earnings and revenue surprises of -100.00% and 7.82%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Milestone Scientific, Inc. (MLSS) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
by Zacks Equity Research
Milestone Scientific, Inc. (MLSS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Implied Volatility Surging for Milestone Scientific (MLSS) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Milestone Scientific (MLSS) stock based on the movements in the options market lately.
Milestone Scientific, Inc. (MLSS) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Milestone Scientific, Inc. (MLSS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Milestone Scientific, Inc. (MLSS) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Milestone Scientific, Inc. (MLSS) delivered earnings and revenue surprises of 66.67% and -37.86%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Milestone Scientific, Inc. (MLSS) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
by Zacks Equity Research
Milestone Scientific, Inc. (MLSS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.